CN101628098A - Medicinal composition used for treating fatty liver and preparation method thereof - Google Patents

Medicinal composition used for treating fatty liver and preparation method thereof Download PDF

Info

Publication number
CN101628098A
CN101628098A CN200810116836A CN200810116836A CN101628098A CN 101628098 A CN101628098 A CN 101628098A CN 200810116836 A CN200810116836 A CN 200810116836A CN 200810116836 A CN200810116836 A CN 200810116836A CN 101628098 A CN101628098 A CN 101628098A
Authority
CN
China
Prior art keywords
parts
fructus
radix
fatty liver
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810116836A
Other languages
Chinese (zh)
Inventor
王丽娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TECH-SKY TECHNOLOGY (BEIJING) Co Ltd
Original Assignee
TECH-SKY TECHNOLOGY (BEIJING) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TECH-SKY TECHNOLOGY (BEIJING) Co Ltd filed Critical TECH-SKY TECHNOLOGY (BEIJING) Co Ltd
Priority to CN200810116836A priority Critical patent/CN101628098A/en
Publication of CN101628098A publication Critical patent/CN101628098A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicinal composition used for treating fatty liver and a preparation method thereof. The effective components of the medicinal composition are extracted from the following medicinal materials: dark plum fruit, baical skullcap root, glossy privet fruit, Chinese angelica, Chinese magnoliavine fruit, hawthorn fruit, bitter orange, tuber fleeceflower root, stir-fried spiny jujube, hiraute shiny bugleweed herb, danshen root, fetid cassia, officinal magnolia bark, villous amomum fruit, raw licorice root, and the like. The medicinal composition has ideal therapeutic effects on non-alcoholic fatty liver.

Description

A kind of drug regimen for the treatment of fatty liver and preparation method thereof
Technical field
The invention belongs to technical field of traditional Chinese medicine pharmacy, be specifically related to a kind of drug regimen for the treatment of fatty liver and preparation method thereof.
Technical background
The fat of human body has two big classes, and a class is a neutral fat, neutral fat can with people's nutriture and body active what change.Another kind of is lipoid, comprises phospholipid, cholesterol and cholesterol ester, is the important component part of human body cell film, also is the important source material of synthetic cholate, vitamin D, steroid hormone, is changeless.
Under normal circumstances, liver only contains little fat, accounts for the 4%-7% of liver weight, and wherein half is a neutral fat, and all the other are lecithin and a spot of cholesterol.Under some abnormal conditions, the fat content in the liver increases, when its fat content surpass liver weight (weight in wet base) 10% the time be fatty liver.Surpassing 10%-25% is the moderate fatty liver, and surpassing 25%-50% is severe fatty liver.
Fatty liver can be divided into two types of ethanol and non-alcoholics clinically.Alcoholic fatty liver with drink relevantly, non-alcoholic fatty liver disease great majority are still with fat relevant with diabetes.
Along with the change of diet and living habit, the incidence rate of non-alcoholic fatty liver disease is improving year by year, has caused in the world the great attention to this disease.Except the reason such as alcohol prohibition, diet control, modest movement and blood sugar control that cause disease at correction, the traditional Chinese medical science thinks that non-alcoholic fatty liver disease belongs to " the lump at the left hypochondrium disease " of the traditional Chinese medical science, " long-pending card ", finally form damp-phlegm stasis of blood resistance knot mutually with the liver failing to maintain the normal flow of QI, dysfunction of the spleen in transportation, retention of damp-heat in the interior, the turbid pent-up of expectorant, stagnation of blood stasis, liver blockage of the vessel and form fatty liver.
Fatty liver belongs to motherland's medical science " hypochondriac pain ", " gathering ", " syndrome of feeling fullness and distension in the upper abdomen " category.According to its clinical manifestation, national standard is named and is " liver addiction ".The primary disease origin cause of formation, exopathogenic factor mostly are the feed greasy and surfeit flavour or are addicted to drink immoderately, give birth to the wet expectorant of making; Endogenous cause of ill is then by the liver failing to maintain the normal flow of QI, dysfunction of the spleen in transportation, and the kidney flatusization, water is wet can not to be turned to precise and tinyly, poly-and be the wet expectorant that is, and stasis of blood resistance liver network is stranded in liver and forms primary disease.
At drug treatment, modern medicine still lacks ideal specificity medicine, mainly from protect the liver, the medication of suiting the medicine to the illness such as blood fat reducing starts with, but the fat-reducing medicament that wherein is applied to hyperlipemia usually is to the effect of fatty liver and be worth and how on earth do not obtain as yet certainly, because of some blood lipid-lowering medicine diminishes the liver side effect, with it improper possibility that the weight fat liver is arranged on the contrary.Therefore, accepted by increasing patient at the Chinese medicine of China's fatty liver.
Summary of the invention:
One of purpose of the present invention provides a kind of drug regimen for the treatment of fatty liver.
Another object of the present invention provides the preparation method of this drug regimen.
Chinese medicine of the present invention is made up of active ingredient and/or pharmaceutically acceptable carrier, and wherein said active ingredient is made (part is unit of weight) by following raw materials according:
1. write out a prescription:
Fructus Mume 60-180 part Radix Scutellariae 80-240 part Fructus Ligustri Lucidi 60-180 part
Radix Angelicae Sinensis 80-240 part Fructus Schisandrae Chinensis 80-240 part Fructus Crataegi 60-180 part
Fructus Aurantii 80-240 part Radix Polygoni Multiflori 80-240 part Semen Ziziphi Spinosae (parched) 60-180 part
Herba Lycopi 60-180 part Radix Salviae Miltiorrhizae 80-240 part Semen Cassiae 60-180 part
Cortex Magnoliae Officinalis 80-240 part Fructus Amomi 60-180 part Radix Glycyrrhizae 60-180 part
The active component that preferred following raw materials according is made, curative effect is better:
120 parts of 160 parts of Fructus Ligustri Lucidi of 120 parts of Radix Scutellariaes of Fructus Mume
120 parts of 160 portions of Fructus Crataegis of 160 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
120 parts of 160 parts of Semen Ziziphi Spinosae (parched)s of 160 parts of Radix Polygoni Multiflori of Fructus Aurantii
120 parts of 160 parts of Semen Cassiae of 120 parts of Radix Salviae Miltiorrhizaes of Herba Lycopi
120 parts of 120 parts of Radix Glycyrrhizae of 160 parts of Fructus Amomis of Cortex Magnoliae Officinalis
The active ingredient preparation method of Chinese medicine of the present invention can be that raw material is dry respectively, and levigation mixes.It also can be the conventional method preparation of adopting herbal pharmaceutical.These pharmacy conventional methods can be water extract-alcohol precipitation or ethanol extract from water precipitation, also have other extracting method in addition, specifically " pharmaceutics of Chinese drugs " published referring to Cao Chunlin chief editor's Shanghai science tech publishing house.
The following preparation method preparation of preferred employing:
2. preparation technology
(1) Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae add 85% alcohol dipping secondary, flood 48 hours for the first time, flood 24 hours for the second time, filter, and decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(2) medical materials such as all the other Fructus Mumes, Radix Scutellariae, Fructus Ligustri Lucidi, Fructus Schisandrae Chinensis, Fructus Crataegi, Fructus Aurantii, Radix Polygoni Multiflori, Semen Ziziphi Spinosae (parched), Herba Lycopi, Semen Cassiae, Cortex Magnoliae Officinalis, Fructus Amomi, Radix Glycyrrhizae add 10 times of decoctings and boil three times, 1 hour for the first time, second and third time 0.5 hour, filter, merging filtrate, filtrate is condensed into the clear paste that relative density is 1.08~1.14 (50~60 ℃), add 2.8 times of amount ethanol, stir evenly, be heated to 60 ℃, left standstill 24 hours, filter, decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(3) step (1) get dry extract is got dry extract with step (2) mix, be ground into fine powder, add acceptable accessories and make different preparations such as granule, sheet, capsule.
By the following examples technical scheme of the present invention is described further.
Specific embodiment
Embodiment 1: the preparation method of granule
1. write out a prescription:
120 parts of 160 parts of Fructus Ligustri Lucidi of 120 parts of Radix Scutellariaes of Fructus Mume
120 parts of 160 portions of Fructus Crataegis of 160 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
120 parts of 160 parts of Semen Ziziphi Spinosae (parched)s of 160 parts of Radix Polygoni Multiflori of Fructus Aurantii
120 parts of 160 parts of Semen Cassiae of 120 parts of Radix Salviae Miltiorrhizaes of Herba Lycopi
120 parts of 120 parts of Radix Glycyrrhizae of 160 parts of Fructus Amomis of Cortex Magnoliae Officinalis
2. preparation technology:
(1) Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae add 85% alcohol dipping secondary, flood 48 hours for the first time, flood 24 hours for the second time, filter, and decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(2) medical materials such as all the other Fructus Mumes, Radix Scutellariae, Fructus Ligustri Lucidi, Fructus Schisandrae Chinensis, Fructus Crataegi, Fructus Aurantii, Radix Polygoni Multiflori, Semen Ziziphi Spinosae (parched), Herba Lycopi, Semen Cassiae, Cortex Magnoliae Officinalis, Fructus Amomi, Radix Glycyrrhizae add 10 times of decoctings and boil three times, 1 hour for the first time, second and third time 0.5 hour, filter, merging filtrate, filtrate is condensed into the clear paste that relative density is 1.08~1.14 (50~60 ℃), add 2.8 times of amount ethanol, stir evenly, be heated to 60 ℃, left standstill 24 hours, filter, decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(3) step (1) get dry extract is got dry extract with step (2) mix, add cane sugar powder, mixing is made granule, drying, promptly.
Embodiment 2: the preparation method of tablet
1. write out a prescription:
120 parts of 160 parts of Fructus Ligustri Lucidi of 120 parts of Radix Scutellariaes of Fructus Mume
120 parts of 160 portions of Fructus Crataegis of 160 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
120 parts of 160 parts of Semen Ziziphi Spinosae (parched)s of 160 parts of Radix Polygoni Multiflori of Fructus Aurantii
120 parts of 160 parts of Semen Cassiae of 120 parts of Radix Salviae Miltiorrhizaes of Herba Lycopi
120 parts of 120 parts of Radix Glycyrrhizae of 160 parts of Fructus Amomis of Cortex Magnoliae Officinalis
2. preparation technology:
(1) Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae add 85% alcohol dipping secondary, flood 48 hours for the first time, flood 24 hours for the second time, filter, and decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(2) medical materials such as all the other Fructus Mumes, Radix Scutellariae, Fructus Ligustri Lucidi, Fructus Schisandrae Chinensis, Fructus Crataegi, Fructus Aurantii, Radix Polygoni Multiflori, Semen Ziziphi Spinosae (parched), Herba Lycopi, Semen Cassiae, Cortex Magnoliae Officinalis, Fructus Amomi, Radix Glycyrrhizae add 10 times of decoctings and boil three times, 1 hour for the first time, second and third time 0.5 hour, filter, merging filtrate, filtrate is condensed into the clear paste that relative density is 1.08~1.14 (50~60 ℃), add 2.8 times of amount ethanol, stir evenly, be heated to 60 ℃, left standstill 24 hours, filter, decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(3) step (1) get dry extract is got dry extract with step (2) mix, pulverize, sieve, add starch, magnesium stearate, tabletting, promptly.
Embodiment 3: the preparation method of capsule
1. write out a prescription:
120 parts of 160 parts of Fructus Ligustri Lucidi of 120 parts of Radix Scutellariaes of Fructus Mume
120 parts of 160 portions of Fructus Crataegis of 160 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
120 parts of 160 parts of Semen Ziziphi Spinosae (parched)s of 160 parts of Radix Polygoni Multiflori of Fructus Aurantii
120 parts of 160 parts of Semen Cassiae of 120 parts of Radix Salviae Miltiorrhizaes of Herba Lycopi
120 parts of 120 parts of Radix Glycyrrhizae of 160 parts of Fructus Amomis of Cortex Magnoliae Officinalis
2. preparation technology:
(1) Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae add 85% alcohol dipping secondary, flood 48 hours for the first time, flood 24 hours for the second time, filter, and decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(2) medical materials such as all the other Fructus Mumes, Radix Scutellariae, Fructus Ligustri Lucidi, Fructus Schisandrae Chinensis, Fructus Crataegi, Fructus Aurantii, Radix Polygoni Multiflori, Semen Ziziphi Spinosae (parched), Herba Lycopi, Semen Cassiae, Cortex Magnoliae Officinalis, Fructus Amomi, Radix Glycyrrhizae add 10 times of decoctings and boil three times, 1 hour for the first time, second and third time 0.5 hour, filter, merging filtrate, filtrate is condensed into the clear paste that relative density is 1.08~1.14 (50~60 ℃), add 2.8 times of amount ethanol, stir evenly, be heated to 60 ℃, left standstill 24 hours, filter, decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(3) step (1) get dry extract is got dry extract with step (2) mix, pulverize, sieve, add starch, mixing is made granule, and drying incapsulates, promptly.

Claims (5)

1, a kind of drug regimen for the treatment of fatty liver is characterized in that being made up of active ingredient and/or pharmaceutically acceptable carrier, and wherein said active ingredient is made by following raw materials according:
Fructus Mume 60-180 part Radix Scutellariae 80-240 part Fructus Ligustri Lucidi 60-180 part
Radix Angelicae Sinensis 80-240 part Fructus Schisandrae Chinensis 80-240 part Fructus Crataegi 60-180 part
Fructus Aurantii 80-240 part Radix Polygoni Multiflori 80-240 part Semen Ziziphi Spinosae (parched) 60-180 part
Herba Lycopi 60-180 part Radix Salviae Miltiorrhizae 80-240 part Semen Cassiae 60-180 part
Cortex Magnoliae Officinalis 80-240 part Fructus Amomi 60-180 part Radix Glycyrrhizae 60-180 part.
2, a kind of drug regimen for the treatment of fatty liver according to claim 1 is characterized in that wherein preparing the preferred following raw materials according of described active ingredient:
120 parts of 160 parts of Fructus Ligustri Lucidi of 120 parts of Radix Scutellariaes of Fructus Mume
120 parts of 160 portions of Fructus Crataegis of 160 parts of Fructus Schisandrae Chinensis of Radix Angelicae Sinensis
120 parts of 160 parts of Semen Ziziphi Spinosae (parched)s of 160 parts of Radix Polygoni Multiflori of Fructus Aurantii
120 parts of 160 parts of Semen Cassiae of 120 parts of Radix Salviae Miltiorrhizaes of Herba Lycopi
120 parts of 120 parts of Radix Glycyrrhizae of 160 parts of Fructus Amomis of Cortex Magnoliae Officinalis.
3, according to the described a kind of drug regimen for the treatment of fatty liver of claim 1-2, it is characterized in that adopting following method to make:
(1) Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae add 85% alcohol dipping secondary, flood 48 hours for the first time, flood 24 hours for the second time, filter, and decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(2) medical materials such as all the other Fructus Mumes, Radix Scutellariae, Fructus Ligustri Lucidi, Fructus Schisandrae Chinensis, Fructus Crataegi, Fructus Aurantii, Radix Polygoni Multiflori, Semen Ziziphi Spinosae (parched), Herba Lycopi, Semen Cassiae, Cortex Magnoliae Officinalis, Fructus Amomi, Radix Glycyrrhizae add 10 times of decoctings and boil three times, 1 hour for the first time, second and third time 0.5 hour, filter, merging filtrate, filtrate is condensed into the clear paste that relative density is 1.08~1.14 (50~60 ℃), add 2.8 times of amount ethanol, stir evenly, be heated to 60 ℃, left standstill 24 hours, filter, decompression filtrate recycling ethanol is condensed into the thick paste shape, and vacuum drying below 85 ℃ becomes dried cream;
(3) step (1) get dry extract is got dry extract with step (2) mix, be ground into fine powder, add acceptable accessories and make different preparations such as granule, sheet, capsule.
4, according to any one described a kind of drug regimen for the treatment of fatty liver among the claim 1-3, it is characterized in that this Chinese medicine composition is an oral formulations.
5, according to the described a kind of drug regimen for the treatment of fatty liver of claim 3-4, it is characterized in that this Chinese medicine composition can be made into granule, capsule, tablet.
CN200810116836A 2008-07-18 2008-07-18 Medicinal composition used for treating fatty liver and preparation method thereof Pending CN101628098A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810116836A CN101628098A (en) 2008-07-18 2008-07-18 Medicinal composition used for treating fatty liver and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810116836A CN101628098A (en) 2008-07-18 2008-07-18 Medicinal composition used for treating fatty liver and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101628098A true CN101628098A (en) 2010-01-20

Family

ID=41573488

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810116836A Pending CN101628098A (en) 2008-07-18 2008-07-18 Medicinal composition used for treating fatty liver and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101628098A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688451A (en) * 2012-05-25 2012-09-26 王兴辉 Chinese medicinal composition for treating alcoholic fatty liver
CN103007081A (en) * 2012-11-27 2013-04-03 鞠法红 Traditional Chinese medicine composition for curing non-alcoholic fatty liver disease
CN106109767A (en) * 2016-07-13 2016-11-16 郑亮 A kind of compound preparation preventing and treating non-alcohol fatty liver

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688451A (en) * 2012-05-25 2012-09-26 王兴辉 Chinese medicinal composition for treating alcoholic fatty liver
CN102688451B (en) * 2012-05-25 2013-08-21 王兴辉 Chinese medicinal composition for treating alcoholic fatty liver
CN103007081A (en) * 2012-11-27 2013-04-03 鞠法红 Traditional Chinese medicine composition for curing non-alcoholic fatty liver disease
CN106109767A (en) * 2016-07-13 2016-11-16 郑亮 A kind of compound preparation preventing and treating non-alcohol fatty liver

Similar Documents

Publication Publication Date Title
CN102343023B (en) Medicinal composition and preparation method and application thereof
CN101239112A (en) Chinese medicinal composition for regulating blood fat and preparation thereof
WO2010135858A1 (en) Pharmaceutical composition and use for preparing medicament thereof
CN102475830B (en) Medicinal composition for treating coronary disease and angina pectoris, preparation method thereof and preparation thereof
CN101524441A (en) Chinese medicinal composition for lipid-lowering and weight-losing and preparation method thereof
CN102397351A (en) Traditional Chinese medicinal composition for treating insomnia
CN101933973B (en) Medicament composition for preventing and treating liver damage
CN101628098A (en) Medicinal composition used for treating fatty liver and preparation method thereof
CN101623485B (en) Dan e women-healthcare granulae
CN103330837B (en) Traditional Chinese medicine composition for curing osteoporosis of menopausal women
CN101045152A (en) Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease concomitant inflammatory swelling
CN102716342B (en) Medicine for treating diabetes
CN102526444A (en) Traditional Chinese medicine composition for invigorating kidney and strengthening yang and preparation method thereof
CN104258188A (en) Healthcare oral solution with efficacy of treating diabetes mellitus
CN1943755B (en) A Chinese traditional medicinal composition for treatment of hypertension and its preparation method
CN1546088A (en) Dysmenorrhea treating Chinese traditional medicine preparation
CN101607063A (en) Drug regimen of a kind of fat-reducing liver-protecting and preparation method thereof
CN101884700A (en) Tea-containing Chinese medicinal composition
CN101543597A (en) Medicine composition for nourishing spleen and kidney and building up healthful vital energy and preparation method thereof
CN101259205A (en) Medicaments assembly for treating adiposis and preparation thereof
CN101732657A (en) Medicine composition
CN101543609A (en) Traditional Chinese medicine for treating breast cancer and preparation method thereof
CN103977154A (en) Pharmaceutical composition for protecting liver
CN101607065A (en) A kind of drug regimen for the treatment of liver-depression spleen-insufficiency type fatty liver
CN103041361B (en) Medicament for treating three-high disease (high cholesterol, high blood pressure, high blood sugar) and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100120